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ttiología  viral  en  neoplasias  hematoló
n  recent  years,  a  group  of  infectious  agents,  mostly  viral  in
ature,  have  been  associated  with  the  development  of
alignant  diseases.  The  ﬁrst  human  oncogenic  virus,  the
pstein-Barr  virus  (EBV),  was  described  51  years  ago,  which
as  isolated  from  pediatric  patients  with  Burkitt’s  lym-
homa  who  resided  in  Equatorial  Africa.  This  discovery
stablished  the  basis  for  viral  oncology,  which  today  recog-
izes  eight  viral  agents  directly  or  indirectly  associated  with
uman  cancer.
EBV  is  a  member  of  the  herpesviruses  family  and
ogether  with  Kaposi’s  sarcoma-associated  herpesvirus  are
he  prototypical  representatives  of  the  subfamily  of  the
ammaherpesviruses.  These  viruses  are  characterized  by
heir  ability  to  signiﬁcantly  induce  lymphomas  and  sarco-
as  in  immunocompromised  individuals.  Similarly,  members
f  the  subfamily  of  the  betaherpesviruses,  such  as  the
ytomegalovirus  (CMV),  human  herpesvirus  type  6  and
uman  herpesvirus  type  7,  are  being  recognized  as  important
gents  associated  with  human  neoplasms  that  favor  tumor
ggressiveness.  CMV  together  with  EBV  are  viral  agents  of
reat  signiﬁcance  for  immunocompromised  individuals,  par-
icularly  those  who  are  treated  with  immunosuppressive
rugs  to  prevent  rejection  after  solid  organ  transplanta-
ion.  All  these  viruses  are  characterized  for  encoding  their
wn  battery  of  genes,  which  imitate  cellular  processes
nd  allow  chronic  infections  to  be  established,  lasting  the
ntire  lifetime  of  the  host.  The  same  genes  that  perpetu-
te  life  of  the  infected  cell  and  interfere  in  its  process  of
eplication  are  the  oncogenes  responsible  for  its  malignant
ransformation.  Understanding  these  persistent  viral  mech-
nisms  will  provide  a  signiﬁcant  control  of  the  associated
iseases.
Currently,  EBV  is  recognized  as  the  oncogenic  agent
ost  strongly  related  with  pediatric  cancers.  In  children,
his  agent  is  associated  with  a  set  of  diseases  ranging
rom  infectious  mononucleosis  to  lymphomas,  particularly
n  immunosuppressed  individuals.  This  special  issue  of  the
oletin  Médico  del  Hospital  Infantil  de  México  (BMHIM)  has
he  objective  of  highlighting  the  growing  importance  of
iral  agents  in  the  development  of  neoplasms  in  the  pedia-
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ric  population,  mainly  EBV,  but  also  of  other  members  of
he  herpesviruses  family.  These  neoplasms  include  post-
ransplant  lymphoproliferative  disease  and  different  types
f  lymphomas,  including  Burkitt’s  lymphoma,  Hodgkin’s  lym-
homa  and  diffuse  large  B-cell  lymphoma.  More  recently,
BV  is  also  recognized  as  the  causal  agent  of  a  fraction  of  the
-cell  lymphomas  and  NK  cell  lymphomas  and  a  new  entity
alled  hemophagocytic  lymphohistiocytosis.  This  issue  of
MHIM  gathers  original  articles,  review  articles  and  clini-
al  case  reports  of  researchers  located  in  different  research
enters  and  hospitals  worldwide  who  share  their  experiences
n  the  study,  diagnosis  and  treatment  of  this  set  of  diseases.
Chabay  and  Preciado  present  the  epidemiological
anorama  of  pediatric  lymphomas  associated  with  EBV  in
rgentina.1 This  work  represents  one  of  the  few  reports  of
ediatric  lymphomas  and  EBV  done  in  developing  countries
nd  out  of  Africa.  It  shows  that  in  a  Latin  American  country
he  epidemiological  behavior  of  these  neoplasms  is  different
rom  that  of  developed  countries,  with  a higher  incidence
f  EBV-positive  cases  and  with  an  earlier  presentation.
Presenting  part  of  the  experience  of  the  medical  cen-
ers  to  which  they  are  afﬁliated,  Martín-Mateos  and  Piquer
rom  Spain2 and  Lee  and  Ko  from  South  Korea3 present  case
eports  of  common  variable  immunodeﬁciency  and  chronic
ctive  EBV  infections,  respectively:  two  diseases  that  have
een  relatively  recently  recognized  as  important  risk  fac-
ors  in  the  development  of  lymphomas.  Jiménez-Hernández
t  al.  from  Mexico  present  a  case  of  hemophagocytic  lym-
hohistiocytosis  probably  associated  with  EBV.4 This  case
ighlights  that  these  types  of  diseases  also  occur  in  Mex-
co,  up  to  now  mainly  studied  in  Asian  countries  or  in  the
.S.  Reyes-Pérez  et  al.,  in  an  original  article,  approach
he  importance  of  continuous  CMV  monitoring  in  pediatric
atients  who  are  pharmacologically  immunosuppressed  due
o  a  solid  organ  transplantation.  This  article  also  conﬁrms
he  importance  of  monitoring  drug  levels  in  the  blood  and
5o  not  be  based  solely  on  the  dosage  given.
In  an  interesting  review  article,  R.  Rochford,  of
he  University  of  Denver,  discusses  epidemiological  and
xperimental  evidence  on  the  probable  mechanisms  of
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transformation  that  occur  in  endemic  Burkitt’s  lymphoma
of  Equatorial  Africa.6 In  this  speciﬁc  type  of  lymphoma,  co-
infection  with  the  Plasmodium  falciparum  parasite,  which
causes  malaria,  is  a  critical  factor.  Taking  into  consider-
ation  the  article  by  Chabay  and  Preciado,  who  arrive  at  the
conclusion  that  the  incidence  of  lymphomas  associated  with
EBV  is  very  high  in  Argentina  and  its  presentation  is  ear-
lier  than  in  developed  countries,1 it  would  be  important  to
identify  which  infections  act  as  co-factors  in  the  develop-
ment  of  Burkitt’s  lymphoma  in  countries  in  which  malaria  is
not  prevalent,  but  where  the  incidence  of  this  EBV-positive
lymphoma  is  high  in  pediatric  populations.
The  Rouce  working  group  from  Baylor  College
of  Medicine,  Houston,  a  world  leader  in  the  area  of
immunotherapy  against  cancer,  presents  an  opinion  based
on  their  personal  experience  on  risk  factors,  diagnosis  and
management  of  posttransplant  lymphoproliferative  diseases
and  EBV.7 Finally,  J.M.  Mejía-Aranguré  discusses  a  model
of  causality  of  pediatric  acute  leukemias  that  includes
infections  as  possible  risk  factors  in  their  development.8
In  summary,  lymphomas  are  the  third  most  common  type
of  cancer  in  the  pediatric  population  and  leukemia  is  the
most  common.  This  special  edition  emphasizes  the  impor-
tance  of  viral  infections,  especially  by  members  of  the
herpesviruses  family,  in  the  development  of  lymphomas,
with  the  objective  of  intensifying  its  study,  especially  in
developing  countries  such  as  Mexico,  with  very  poor  under-
standing  in  this  regard.  The  study  of  viruses  associated  with
malignant  processes  has  resulted  in  the  Nobel  Prize  for  Dr.
Harald  zur  Hausen  for  the  discovery  of  the  human  papil-
loma  virus  and  for  Dr.  Luc  Montagnier  for  the  discovery  of
the  human  immunodeﬁciency  virus.  This  knowledge  has  also
resulted  in  the  generation  of  two  vaccines  that  will  help  in
the  control  of  cervical  cancer  and  liver  cancer.  In  the  future,
it  is  advisable  to  have  better  tools  for  the  control  of  pedi-
atric  malignancies,  which  are  importantly  associated  with
viral  infections. e3
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